Literature DB >> 34098033

CPR compression strategy 30:2 is difficult to adhere to, but has better survival than continuous chest compressions when done correctly.

Robert H Schmicker1, Graham Nichol2, Peter Kudenchuk3, Jim Christenson4, Christian Vaillancourt5, Henry E Wang6, Tom P Aufderheide7, Ahamed H Idris8, Mohamud R Daya9.   

Abstract

BACKGROUND: A large, randomized trial showed no significant difference in survival to discharge between cardiopulmonary resuscitation (CPR) strategies of 30 compressions with pause for 2 ventilations per cycle (30:2) and continuous chest compression with asynchronous ventilations (CCC). Data from the same trial suggested that adherence to the intended CPR strategy was associated with significantly greater survival. We sought to determine the adherence rate with intended strategy and then explore the association of adherence with survival to discharge in the Resuscitation Outcomes Consortium (ROC).
METHODS: This secondary analysis of data from the ROC included three interventional trials and a prospective registry. We modified an automated software algorithm that classified care as 30:2 or CCC before intubation based on compression segment length (defined as the elapsed time from start of compressions to subsequent pause of ≥2 s), number of pauses per minute ≥2 s in length and chest compression fraction. Intended CPR strategy for individual agencies was based on study randomization (during trial phase) or local standard of care (during registry phase). We defined CPR delivered as adherent when its classification matched the intended strategy. We characterized adherence with intended strategy across trial and registry periods. We examined its association with survival to hospital discharge using multivariate logistic regression after adjustment for Utstein and other potential confounders. Effect modification with intended strategy was assessed through a multiplicative interaction term.
RESULTS: Included were 26,810 adults with out of hospital cardiac arrest, of which 10,942 had an intended strategy of 30:2 and 15,868 an intended strategy of CCC. The automated algorithm classified 12,276 cases as CCC, 7037 as 30:2 and left 7497 as unclassified. Adherence to intended strategy was 54.4%; this differed by intended strategy (58.6% for CCC vs 48.3% for 30:2). Overall adherence was less during the registry phase as compared to during the trial phase(s). The association between adherence and survival was modified by treatment arm (CCC OR: 0.72, 95% CI: 0.64-0.81 vs 30:2 OR: 1.05, 95% CI: 0.90-1.22; interaction p-value<0.01) after adjustment for known confounders.
CONCLUSION: For intended strategy CCC, survival was significantly lower, OR (95%CI) = 0.72 (0.64, 0.81), when adhered to while for intended strategy 30:2, survival was higher, OR (95%CI) = 1.05 (0.90, 1.22), when adhered to. Intended strategy of 30:2 had lower adherence rates than CCC possibly a result of being a more difficult strategy to administer.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  30:2; Adherence; Cardiopulmonary arrest; Continuous compressions

Mesh:

Year:  2021        PMID: 34098033      PMCID: PMC8324555          DOI: 10.1016/j.resuscitation.2021.05.027

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   6.251


  20 in total

Review 1.  Part 5: Adult Basic Life Support and Cardiopulmonary Resuscitation Quality: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Authors:  Monica E Kleinman; Erin E Brennan; Zachary D Goldberger; Robert A Swor; Mark Terry; Bentley J Bobrow; Raúl J Gazmuri; Andrew H Travers; Thomas Rea
Journal:  Circulation       Date:  2015-11-03       Impact factor: 29.690

2.  Trial of Continuous or Interrupted Chest Compressions during CPR.

Authors:  Graham Nichol; Brian Leroux; Henry Wang; Clifton W Callaway; George Sopko; Myron Weisfeldt; Ian Stiell; Laurie J Morrison; Tom P Aufderheide; Sheldon Cheskes; Jim Christenson; Peter Kudenchuk; Christian Vaillancourt; Thomas D Rea; Ahamed H Idris; Riccardo Colella; Marshal Isaacs; Ron Straight; Shannon Stephens; Joe Richardson; Joe Condle; Robert H Schmicker; Debra Egan; Susanne May; Joseph P Ornato
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

3.  Resuscitation Outcomes Consortium-Amiodarone, Lidocaine or Placebo Study (ROC-ALPS): Rationale and methodology behind an out-of-hospital cardiac arrest antiarrhythmic drug trial.

Authors:  Peter J Kudenchuk; Siobhan P Brown; Mohamud Daya; Laurie J Morrison; Brian E Grunau; Tom Rea; Tom Aufderheide; Judy Powell; Brian Leroux; Christian Vaillancourt; Jonathan Larsen; Lynn Wittwer; M Riccardo Colella; Shannon W Stephens; Mark Gamber; Debra Egan; Paul Dorian
Journal:  Am Heart J       Date:  2014-03-01       Impact factor: 4.749

4.  Study Monitoring in Emergency Care Trials: Lessons from the Resuscitation Outcomes Consortium Continuous Chest Compressions Trial.

Authors:  Robert H Schmicker; Graham Nichol; Clifton W Callaway; Sheldon Cheskes; George Sopko; Henry E Wang
Journal:  Acad Emerg Med       Date:  2019-06-23       Impact factor: 3.451

5.  The association between AHA CPR quality guideline compliance and clinical outcomes from out-of-hospital cardiac arrest.

Authors:  Sheldon Cheskes; Robert H Schmicker; Tom Rea; Laurie J Morrison; Brian Grunau; Ian R Drennan; Brian Leroux; Christian Vaillancourt; Terri A Schmidt; Allison C Koller; Peter Kudenchuk; Tom P Aufderheide; Heather Herren; Katharyn H Flickinger; Mark Charleston; Ron Straight; Jim Christenson
Journal:  Resuscitation       Date:  2017-05-02       Impact factor: 5.262

6.  Manual chest compression vs use of an automated chest compression device during resuscitation following out-of-hospital cardiac arrest: a randomized trial.

Authors:  Al Hallstrom; Thomas D Rea; Michael R Sayre; James Christenson; Andy R Anton; Vince N Mosesso; Lois Van Ottingham; Michele Olsufka; Sarah Pennington; Lynn J White; Stephen Yahn; James Husar; Mary F Morris; Leonard A Cobb
Journal:  JAMA       Date:  2006-06-14       Impact factor: 56.272

7.  Design and implementation of the Resuscitation Outcomes Consortium Pragmatic Airway Resuscitation Trial (PART).

Authors:  Henry E Wang; David K Prince; Shannon W Stephens; Heather Herren; Mohamud Daya; Neal Richmond; Jestin Carlson; Craig Warden; M Riccardo Colella; Ashley Brienza; Tom P Aufderheide; Ahamed H Idris; Robert Schmicker; Susanne May; Graham Nichol
Journal:  Resuscitation       Date:  2016-02-02       Impact factor: 5.262

8.  Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.

Authors:  Peter J Kudenchuk; Siobhan P Brown; Mohamud Daya; Thomas Rea; Graham Nichol; Laurie J Morrison; Brian Leroux; Christian Vaillancourt; Lynn Wittwer; Clifton W Callaway; James Christenson; Debra Egan; Joseph P Ornato; Myron L Weisfeldt; Ian G Stiell; Ahamed H Idris; Tom P Aufderheide; James V Dunford; M Riccardo Colella; Gary M Vilke; Ashley M Brienza; Patrice Desvigne-Nickens; Pamela C Gray; Randal Gray; Norman Seals; Ron Straight; Paul Dorian
Journal:  N Engl J Med       Date:  2016-04-04       Impact factor: 91.245

9.  Incidence, outcomes and guideline compliance of out-of-hospital maternal cardiac arrest resuscitations: A population-based cohort study.

Authors:  Alain A Lipowicz; Sheldon Cheskes; Sara H Gray; Farida Jeejeebhoy; Janice Lee; Damon C Scales; Cathy Zhan; Laurie J Morrison
Journal:  Resuscitation       Date:  2018-09-07       Impact factor: 5.262

10.  Chest compression rates and pediatric in-hospital cardiac arrest survival outcomes.

Authors:  Robert M Sutton; Ron W Reeder; William Landis; Kathleen L Meert; Andrew R Yates; John T Berger; Christopher J Newth; Joseph A Carcillo; Patrick S McQuillen; Rick E Harrison; Frank W Moler; Murray M Pollack; Todd C Carpenter; Daniel A Notterman; Richard Holubkov; J Michael Dean; Vinay M Nadkarni; Robert A Berg
Journal:  Resuscitation       Date:  2018-07-18       Impact factor: 6.251

View more
  1 in total

1.  The association of race with CPR quality following out-of-hospital cardiac arrest.

Authors:  Robert H Schmicker; Audrey Blewer; Joshua R Lupton; Tom P Aufderheide; Henry E Wang; Ahamed H Idris; Elisabete Aramendi; Mohamed B Hagahmed; Owen T Traynor; M Riccardo Colella; Mohamud R Daya
Journal:  Resuscitation       Date:  2021-12-03       Impact factor: 5.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.